Search Orphan Drug Designations and Approvals
-
| Generic Name: | autologous adult bone marrow-derived and unexpanded CD133+ hematopoietic stem cells (CD133+ BMDSCs) mobilized from peripheral blood (PB) |
|---|---|
| Date Designated: | 02/01/2019 |
| Orphan Designation: | Treatment of women with infertility and a thin endometrium seeking pregnancy |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Asherman Therapy S.L.U. Ronda Narcís Monturiol Estarriol nº11 Parcela B, Edificio Europark Valencia Spain The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







